170 related articles for article (PubMed ID: 7734297)
1. Inhibin as a marker for ovarian cancer.
Cooke I; O'Brien M; Charnock FM; Groome N; Ganesan TS
Br J Cancer; 1995 May; 71(5):1046-50. PubMed ID: 7734297
[TBL] [Abstract][Full Text] [Related]
2. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours.
Burger HG; Robertson DM; Cahir N; Mamers P; Healy DL; Jobling T; Groome N
Clin Endocrinol (Oxf); 1996 Apr; 44(4):413-8. PubMed ID: 8706307
[TBL] [Abstract][Full Text] [Related]
3. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.
Robertson DM; Stephenson T; Pruysers E; McCloud P; Tsigos A; Groome N; Mamers P; Burger HG
J Clin Endocrinol Metab; 2002 Feb; 87(2):816-24. PubMed ID: 11836327
[TBL] [Abstract][Full Text] [Related]
4. Granulosa cell tumors of the ovary and inhibin B.
Lyubimova NV; Beyshembaev AM; Kushlinskiy DN; Zordania KI; Adamyan LV
Bull Exp Biol Med; 2011 Mar; 150(5):635-8. PubMed ID: 22235403
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumours of the ovary.
Arora DS; Cooke IE; Ganesan TS; Ramsdale J; Manek S; Charnock FM; Groome NP; Wells M
J Pathol; 1997 Apr; 181(4):413-8. PubMed ID: 9196439
[TBL] [Abstract][Full Text] [Related]
6. Inhibin forms in serum from postmenopausal women with ovarian cancers.
Robertson DM; Cahir N; Burger HG; Mamers P; Groome N
Clin Endocrinol (Oxf); 1999 Mar; 50(3):381-6. PubMed ID: 10435065
[TBL] [Abstract][Full Text] [Related]
7. Inhibins/activins as diagnostic markers for ovarian cancer.
Robertson DM; Stephenson T; Pruysers E; Burger HG; McCloud P; Tsigos A; Groome N; Mamers P; McNeilage J; Jobling T; Healy D
Mol Cell Endocrinol; 2002 May; 191(1):97-103. PubMed ID: 12044923
[TBL] [Abstract][Full Text] [Related]
8. Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay.
Lambert-Messerlian GM; Hall JE; Sluss PM; Taylor AE; Martin KA; Groome NP; Crowley WF; Schneyer AL
J Clin Endocrinol Metab; 1994 Jul; 79(1):45-50. PubMed ID: 8027251
[TBL] [Abstract][Full Text] [Related]
9. The inhibins and ovarian cancer.
Burger HG; Fuller PJ; Chu S; Mamers P; Drummond A; Susil B; Neva P; Robertson DM
Mol Cell Endocrinol; 2001 Jun; 180(1-2):145-8. PubMed ID: 11451584
[TBL] [Abstract][Full Text] [Related]
10. Peripheral vein, ovarian vein and ovarian tissue levels of inhibin in a postmenopausal patient with a granulosa cell tumour.
Sluijmer AV; Heineman MJ; Evers JL; de Jong FH
Acta Endocrinol (Copenh); 1993 Oct; 129(4):311-4. PubMed ID: 8237248
[TBL] [Abstract][Full Text] [Related]
11. Juvenile granulosa cell tumor in association with a high serum inhibin level.
Nishida M; Jimi S; Haji M; Hayashi I; Kai T; Tasaka H
Gynecol Oncol; 1991 Jan; 40(1):90-4. PubMed ID: 1989922
[TBL] [Abstract][Full Text] [Related]
12. Inhibin as a marker for granulosa-cell tumors.
Lappöhn RE; Burger HG; Bouma J; Bangah M; Krans M; de Bruijn HW
N Engl J Med; 1989 Sep; 321(12):790-3. PubMed ID: 2770810
[TBL] [Abstract][Full Text] [Related]
13. [Value of inhibin as a tumor marker in granulosa cell tumors. Apropos of 6 new cases treated at the Gustave-Roussy Institute].
Pautier P; Bidart JM; Lallou N; Duvillard P; Michel G; Droz JP; Lhommé C
Bull Cancer; 1995 Jul; 82(7):557-60. PubMed ID: 7549118
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin.
Muttukrishna S; Fowler PA; Groome NP; Mitchell GG; Robertson WR; Knight PG
Hum Reprod; 1994 Sep; 9(9):1634-42. PubMed ID: 7836513
[TBL] [Abstract][Full Text] [Related]
15. Antimüllerian hormone as a serum marker of granulosa cell tumorsof the ovary: comparative study with serum alpha-inhibin and estradiol.
Rey RA; Lhommé C; Marcillac I; Lahlou N; Duvillard P; Josso N; Bidart JM
Am J Obstet Gynecol; 1996 Mar; 174(3):958-65. PubMed ID: 8633676
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of inhibin in granulosa cell tumors of the ovary.
Jobling T; Mamers P; Healy DL; MacLachlan V; Burger HG; Quinn M; Rome R; Day AJ
Gynecol Oncol; 1994 Nov; 55(2):285-9. PubMed ID: 7959297
[TBL] [Abstract][Full Text] [Related]
17. Inhibin as a marker for granulosa cell tumor.
Lappöhn RE; Burger HG; Bouma J; Bangah M; Krans M
Acta Obstet Gynecol Scand Suppl; 1992; 155():61-5. PubMed ID: 1502891
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathophysiological aspects of inhibin.
Healy DL; Mamers P; Bangah M; Burger HG
Hum Reprod; 1993 Nov; 8 Suppl 2():138-40. PubMed ID: 8276948
[TBL] [Abstract][Full Text] [Related]
19. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay.
Groome NP; Illingworth PJ; O'Brien M; Cooke I; Ganesan TS; Baird DT; McNeilly AS
Clin Endocrinol (Oxf); 1994 Jun; 40(6):717-23. PubMed ID: 8033361
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.
Healy DL; Burger HG; Mamers P; Jobling T; Bangah M; Quinn M; Grant P; Day AJ; Rome R; Campbell JJ
N Engl J Med; 1993 Nov; 329(21):1539-42. PubMed ID: 8413476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
